Evaluation of the time-course of CYP Induction and impact on drug interaction risk assessment from the IQ Induction working group

Drug Metabolism and Pharmacokinetics ◽

10.1016/j.dmpk.2018.09.146 ◽

2019 ◽

Vol 34 (1) ◽

pp. S40

Author(s):

Niresh Hariparsad ◽

Heidi Einolf ◽

David Buckley ◽

Shannon Dallas ◽

Josh Dekeyser ◽

...

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Download Full-text

Correction to “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro CYP Induction Studies Including Impact on Drug Interaction Risk Assessment”

Drug Metabolism and Disposition ◽

10.1124/dmd.120.000055err ◽

2021 ◽

Vol 49 (4) ◽

pp. 344-344

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Model Fitting ◽

Regulatory Agencies ◽

Cyp Induction ◽

Drug Drug Interaction

Download Full-text

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment

Drug Metabolism and Disposition ◽

10.1124/dmd.120.000055 ◽

2020 ◽

Vol 49 (1) ◽

pp. 94-110

Author(s):

Simon G. Wong ◽

Diane Ramsden ◽

Shannon Dallas ◽

Conrad Fung ◽

Heidi J. Einolf ◽

...

Keyword(s):

Risk Assessment ◽

Cytochrome P450 ◽

Drug Interaction ◽

Working Group ◽

Time Course ◽

Model Fitting ◽

Regulatory Agencies ◽

Cytochrome P450 Induction ◽

Drug Drug Interaction

Download Full-text

Recommendations for in vitro CYP3A4 mRNA data analysis for drug-drug interaction risk assessment from the IQ Induction working group

Drug Metabolism and Pharmacokinetics ◽

10.1016/j.dmpk.2018.09.159 ◽

2019 ◽

Vol 34 (1) ◽

pp. S44

Author(s):

Donald Tweedie ◽

Jane R. Kenny ◽

Diane Ramsden ◽

David Buckley ◽

Shannon Dallas ◽

...

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Data Analysis ◽

Working Group ◽

Drug Drug Interaction

Download Full-text

A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

Case Medical Research ◽

10.31525/ct1-nct04166669 ◽

2019 ◽

Author(s):

Keyword(s):

Drug Interaction ◽

Interaction Study ◽

Drug Interaction Study ◽

Cyp3a4 Inhibition ◽

Cyp Induction ◽

Drug Drug Interaction

Download Full-text

Faculty Opinions recommendation of Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718043074.793480891 ◽

2013 ◽

Author(s):

Bruno Stieger

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Decision Criteria ◽

Inhibitory Potency ◽

Experimental Systems ◽

P Glycoprotein ◽

Drug Drug Interaction

Download Full-text

Recent and future activities of the OECD Nuclear Energy Agency Working Group on RISK assessment (WGRISK)

Safety and Reliability of Complex Engineered Systems ◽

10.1201/b19094-80 ◽

2015 ◽

pp. 581-585

Author(s):

M Röwekamp ◽

V Dang ◽

R Gheorghe ◽

J Lanore ◽

K Coyne

Keyword(s):

Risk Assessment ◽

Working Group ◽

Nuclear Energy ◽

Download Full-text

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

European Journal of Human Genetics ◽

10.1038/s41431-021-00969-9 ◽

2021 ◽

Author(s):

Maja Matic ◽

Marga Nijenhuis ◽

Bianca Soree ◽

Nienke J. de Boer-Veger ◽

Anne-Marie Buunk ◽

...

Keyword(s):

Drug Interaction ◽

Download Full-text

DRUG INTERACTION WORKING GROUP : JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION

Drug Metabolism and Pharmacokinetics ◽

10.2133/dmpk.14.supplement_150 ◽

1999 ◽

Vol 14 (supplement) ◽

pp. 150-151

Author(s):

Satoshi Kobayashi

Keyword(s):

Drug Interaction ◽

Working Group ◽

Pharmaceutical Manufacturers

Download Full-text

Urinary bladder carcinogenesis: A working group approach to risk assessment

Food and Chemical Toxicology ◽

10.1016/0278-6915(95)00038-4 ◽

1995 ◽

Vol 33 (9) ◽

pp. 701-704 ◽

Author(s):

D.A. Neumann ◽

S.S. Olin

Keyword(s):

Risk Assessment ◽

Urinary Bladder ◽

Working Group ◽

Group Approach ◽

Bladder Carcinogenesis

Download Full-text

Risk Assessment for Drug-Drug Interaction Caused by Metabolism-Based Inhibition of CYP3A Using Automated in Vitro Assay Systems and Its Application in the Early Drug Discovery Process

Drug Metabolism and Disposition ◽

10.1124/dmd.107.015016 ◽

2007 ◽

Vol 35 (7) ◽

pp. 1232-1238 ◽

Author(s):

Akiko Watanabe ◽

Koichi Nakamura ◽

Noriko Okudaira ◽

Osamu Okazaki ◽

Ken-ichi Sudo

Keyword(s):

Risk Assessment ◽

Drug Interaction ◽

Drug Discovery ◽

In Vitro Assay ◽

Discovery Process ◽

Drug Discovery Process ◽

Vitro Assay ◽

Drug Drug Interaction ◽

Download Full-text